GreenLight Biosciences
(NASDAQ) GRNA
GreenLight Biosciences Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$10.20M
Net Income (TTM)
$158.07M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
GRNA News
GRNA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout GreenLight Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
262
CEO
Andrey J. Zarur, PhD
Headquarters
Medford, MA 02155, US
GRNA Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-26%
Net Income Margin
-26%
Return on Equity
-18%
Return on Capital
-1%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$6.38M
Operating Income
$163.92M
EBITDA
$153.99M
Operating Cash Flow
$136.73M
Capital Expenditure
$26.55M
Free Cash Flow
$163.28M
Cash & ST Invst.
$68.10M
Total Debt
$80.48M
GreenLight Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$3.82M
+1386.4%
Gross Profit
$3.82M
+1386.4%
Gross Margin
100.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
280
N/A
Net Income
$28.04M
+27.3%
EBITDA
$25.36M
+27.6%
Quarterly Fundamentals
Net Cash
$45.08M
-190.7%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$59.56M
+151.5%
Short Term Debt
$17.86M
+81.4%
Return on Assets
-1.12%
N/A
Return on Invested Capital
-1.45%
N/A
Free Cash Flow
$32.67M
+34.3%
Operating Cash Flow
$31.06M
+37.2%